Stay updated on Guselkumab vs Ustekinumab in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.

Latest updates to the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s revision tag was updated from v3.5.3 to v3.5.4, signaling a minor version update in the content management system. This appears to be a behind-the-scenes change rather than a modification to user-visible content.SummaryDifference0.0%

- Check26 days agoChange DetectedThe Taiwan location entry Taoyuan District, Taiwan was removed and Taoyuan, Taiwan was added to the study's list of sites, updating the geographic coverage in Taiwan.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page’s displayed application/version revision updates from v3.5.0 to v3.5.3, reflecting a software release without changing the study details.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision tag updated to v3.4.3, replacing the prior v3.4.2.SummaryDifference0.0%

- Check111 days agoChange DetectedRevision: v3.4.2 is now displayed on the page, and the previous funding-status notice as well as Revision: v3.4.1 have been removed. No study content, eligibility criteria, or user actions are affected by this change.SummaryDifference0.3%

Stay in the know with updates to Guselkumab vs Ustekinumab in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.